Literature DB >> 25332612

Ischemic stroke in a patient with hetrozygous factor v leiden mutation: an uncommon association.

P S Ghalaut1, Joginder Duhan1, Vikas Chaudhary1, Hemant Krishan Dahiya1, Sumin Kaushik1, Manisha Sharma1, Jitendra Kumar Pehalajani1.   

Abstract

Entities:  

Year:  2014        PMID： 25332612      PMCID： PMC4192229          DOI： 10.1007/s12288-014-0392-2

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  13 in total

Review 1.  Management of patients with hereditary hypercoagulable disorders.

Authors:  C Kearon; M Crowther; J Hirsh
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

2.  Investigation and management of heritable thrombophilia.

Authors: 
Journal:  Br J Haematol       Date:  2001-09       Impact factor: 6.998

Review 3.  Clinical practice. Care of patients receiving long-term anticoagulant therapy.

Authors:  Sam Schulman
Journal:  N Engl J Med       Date:  2003-08-14       Impact factor: 91.245

Review 4.  Risk factors for venous thrombosis - current understanding from an epidemiological point of view.

Authors:  Willem M Lijfering; Frits R Rosendaal; Suzanne C Cannegieter
Journal:  Br J Haematol       Date:  2010-04-29       Impact factor: 6.998

5.  Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males.

Authors:  A Inbal; D Freimark; B Modan; A Chetrit; S Matetzky; N Rosenberg; R Dardik; Z Baron; U Seligsohn
Journal:  Blood       Date:  1999-04-01       Impact factor: 22.113

6.  Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke.

Authors:  A J C Slooter; F R Rosendaal; B C Tanis; J M Kemmeren; Y van der Graaf; A Algra
Journal:  J Thromb Haemost       Date:  2005-06       Impact factor: 5.824

7.  Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency.

Authors:  B Zöller; J Holm; P Svensson; B Dahlbäck
Journal:  Thromb Haemost       Date:  1996-02       Impact factor: 5.249

8.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

9.  Ischaemic stroke patients with heterozygous factor V Leiden present with multiple brain infarctions and widespread atherothrombotic disease.

Authors:  Elena Haapaniemi; Johanna Helenius; Dimitrije Jakovljević; Lauri Soinne; Martti Syrjälä; Markku Kaste; Riitta Lassila; Turgut Tatlisumak
Journal:  Thromb Haemost       Date:  2009-01       Impact factor: 5.249

10.  Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation.

Authors:  P Simioni; L Scarano; S Gavasso; C Sardella; B Girolami; A Scudeller; A Girolami
Journal:  Br J Haematol       Date:  1996-02       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.